Zelsuvmi Side Effects
Generic name: berdazimer topical
Note: This document contains side effect information about berdazimer topical. Some dosage forms listed on this page may not apply to the brand name Zelsuvmi.
Applies to berdazimer topical: topical gel.
General
The most commonly reported side effects in more than or equal to 1% of patients were application site reactions, including pain (such as burning or stinging sensations), erythema, pruritus, exfoliation, dermatitis, swelling, erosion, discoloration, vesicles, irritation, and infection.[Ref]
Gastrointestinal
Uncommon (0.1% to 1%): Vomiting[Ref]
Local
Very common (10% or more): Application site pain (12.3%)
Common (1% to 10%): Application site dermatitis, application site erythema, application site exfoliation, application site pruritus, application site swelling, application site discoloration, application site vesicles
Uncommon (0.1% to 1%): Application site erosion, application site irritation, application site infection[Ref]
Application site pain included application site burning and stinging.[Ref]
Other
Very common (10% or more): Treatment emergent adverse events (24%)
Common (1% to 10%): Pyrexia[Ref]
Respiratory
Uncommon (0.1% to 1%): Upper respiratory tract infection[Ref]
More about Zelsuvmi (berdazimer topical)
- Compare alternatives
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous topical agents
Patient resources
Professional resources
Related treatment guides
References
1. (2024) "Product Information. Zelsuvmi (berdazimer topical)." Ligand Pharmaceuticals
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.